Communiqués Spermosens AB

Actions

SPERM

SE0015346424

Cours en clôture NORDIC GROWTH MARKET 21/08/2026			Varia. 5j.	Varia. 1 janv.
0,009200 ^SEK	+17,95%		-4,17%	+58,62%

20/08	Spermosens : creusement modéré de la perte, le recrutement des patients dépasse les attentes selon la direction	FW
20/08	Spermosens AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

21/08	Spermosens: Spermosens AB (publ) to Host Live Q&A Webcast on 27 August 2026	PU
21/08	Spermosens AB (publ) to Host Live Q&A Webcast on 27 August 2026	AQ
20/08	Spermosens: Spermosens AB (publ) INTERIM REPORT APRIL – JUNE 2026	PU
20/08	Spermosens AB (publ) INTERIM REPORT APRIL - JUNE 2026	AQ
06/08	Spermosens: Notice of Extraordinary General Meeting in Spermosens AB (publ)	PU
06/08	Notice of Extraordinary General Meeting in Spermosens AB (publ)	AQ
06/08	Spermosens: Spermosens raises approx. SEK 4.85m in directed issue and calls EGM	PU
06/08	Spermosens raises approx. SEK 4.85m in directed issue and calls EGM	AQ
21/07	Spermosens calls SEK 4.85 million under previously announced Capital Facility	AQ
01/07	Spermosens provides an update on the Generation 3 clinical study	AQ
18/06	Bulletin from Annual General Meeting in Spermosens AB (publ)	AQ
28/05	Spermosens publishes annual report for the financial year 2025	AQ
18/05	NOTICE OF ANNUAL GENERAL MEETING 2026 IN SPERMOSENS AB (publ)	AQ
11/05	Spermosens AB (publ) to Host Live Q&A Webcast on 19 May 2026	AQ
07/05	Spermosens secures SEK 4.85 million capital facility to support development and commercialization	AQ
07/05	Spermosens AB (publ) INTERIM REPORT JANUARY - MARCH 2026	AQ
29/04	Spermosens reports JUNO-Checked Generation 3 clinical validation study on track	AQ
08/04	Spermosens: Spermosens completes development of JUNO-Checked Generation 3 and initiates clinical validation study	PU
08/04	Spermosens completes development of JUNO-Checked Generation 3 and initiates clinical validation study	AQ
25/03	Spermosens AB (publ) Issues Final Reminder for Tomorrow's Live Q&A Webcast	AQ
16/03	Spermosens AB (publ) to Host Live Q&A Webcast Following Recent Progress	AQ
11/02	Spermosens: Spermosens AB (publ)YEAR-END REPORT JANUARY – DECEMBER 2025	PU
11/02	Spermosens AB (publ)YEAR-END REPORT JANUARY - DECEMBER 2025	AQ
26/01	Spermosens and RSI sign Memorandum of Understanding to advance male fertility diagnostics in the US	AQ
16/01	Spermosens and Sapyen sign Memorandum of Understanding to advance male fertility diagnostics	AQ